Výsledky vyhledávání - Kanwal Raghav
- Zobrazuji výsledky 1 - 20 z 59
- Přejít na další stránku
-
1
Molecular Pathways and Mechanisms of HER2 in Cancer Therapy Autor Kanwal Raghav, Mark M. Moasser
Vydáno 2022Revisão -
2
-
3
Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance) Autor Kanwal Raghav, Fang‐Shu Ou, Alan P. Venook, Federico Innocenti, Ryan Sun, Heinz‐Josef Lenz, Scott Kopetz
Vydáno 2022Artigo -
4
Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies Autor Joseph M. Unger, Dawn L. Hershman, Raymond U. Osarogiagbon, Anirudh Gothwal, Seerat Anand, Arvind Dasari, Michael J. Overman, Jonathan M. Loree, Kanwal Raghav
Vydáno 2020Artigo -
5
Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer Autor Funda Meric‐Bernstam, Amber M. Johnson, Ecaterina E. Dumbrava, Kanwal Raghav, Kavitha Balaji, Michelle Bhatt, Rashmi K. Murthy, Jordi Rodón, Sarina A. Piha‐Paul
Vydáno 2018Revisão -
6
Plasma HER2 (<i>ERBB2</i>) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer Autor Giulia Siravegna, Andrea Sartore‐Bianchi, Rebecca J. Nagy, Kanwal Raghav, Justin I. Odegaard, Richard B. Lanman, Livio Trusolino, Silvia Marsoni, Salvatore Siena, Alberto Bardelli
Vydáno 2019Artigo -
7
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018 Autor Jonathan M. Loree, Seerat Anand, Arvind Dasari, Joseph M. Unger, Anirudh Gothwal, Lee M. Ellis, Gauri Varadhachary, Scott Kopetz, Michael J. Overman, Kanwal Raghav
Vydáno 2019Artigo -
8
Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study... Autor Pat Gulhati, Kanwal Raghav, Rachna T. Shroff, Gauri R. Varadhachary, Scott Kopetz, Milind Javle, Wei Qiao, Huamin Wang, Jeffrey S. Morris, Robert A. Wolff, Michael J. Overman
Vydáno 2016Artigo -
9
cMET and Phospho-cMET Protein Levels in Breast Cancers and Survival Outcomes Autor Kanwal Raghav, Wenting Wang, Shuying Liu, Mariana Chávez‐MacGregor, Xiaolong Meng, Gabriel N. Hortobágyi, Gordon B. Mills, Funda Meric‐Bernstam, George R. Blumenschein, Ana M. González-Angulo
Vydáno 2012Artigo -
10
International Harmonization of Provisional Diagnostic Criteria for <i>ERBB2</i>-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing Panel Autor Satoshi Fujii, Anthony M. Magliocco, Jihun Kim, Wataru Okamoto, Jeong Eun Kim, Kentaro Sawada, Yoshiaki Nakamura, Scott Kopetz, Woong‐Yang Park, Katsuya Tsuchihara, Tae Won Kim, Kanwal Raghav, Takayuki Yoshino
Vydáno 2020Artigo -
11
Impact of low estrogen/progesterone receptor expression on survival outcomes in breast cancers previously classified as triple negative breast cancers Autor Kanwal Raghav, Leonel F. Hernandez‐Aya, Xiudong Lei, Mariana Chávez‐MacGregor, Funda Meric‐Bernstam, Thomas A. Buchholz, Ayşegül A. Şahin, Kors Jan A., Gabriel N. Hortobágyi, Ana M. González-Angulo
Vydáno 2011Artigo -
12
Impact of Molecular Alterations and Targeted Therapy in Appendiceal Adenocarcinomas Autor Kanwal Raghav, Aditya Shetty, Syed Mohammad Ali Kazmi, Nianxiang Zhang, Jeffrey S. Morris, Melissa W. Taggart, Keith F. Fournier, Richard E. Royal, Paul Mansfield, Cathy Eng, Robert A. Wolff, Michael J. Overman
Vydáno 2013Artigo -
13
Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older Autor Jonathan D. Mizrahi, Jane E. Rogers, Kenneth R. Hess, Robert A. Wolff, Gauri R. Varadhachary, Milind Javle, Rachna T. Shroff, Linus Ho, David R. Fogelman, Kanwal Raghav, Michael J. Overman, Shubham Pant
Vydáno 2020Artigo -
14
Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients Autor Suguru Yamashita, Eugene J. Koay, Guillaume Passot, Rachna T. Shroff, Kanwal Raghav, Claudius Conrad, Yun Shin Chun, Thomas A. Aloia, Randa Tao, Ahmed O. Kaseb, Milind Javle, Christopher H. Crane, Jean‐Nicolas Vauthey
Vydáno 2016Artigo -
15
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia Autor Michael J. Overman, Renata Ferrarotto, Kanwal Raghav, Binsah George, Wei Qiao, Karime Kalil Machado, Leonard B. Saltz, Thibault Mazard, Jean‐Nicolas Vauthey, Paulo M. Hoff, Brian P. Hobbs, Evelyn Loyer, Scott Kopetz
Vydáno 2017Artigo -
16
Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer Autor Kanwal Raghav, John Paul Shen, Alexandre A. Jácome, Jennifer L. Guerra, Christopher P. Scally, Melissa W. Taggart, Wai Chin Foo, Aurelio Matamoros, Kenna Shaw, Keith F. Fournier, Michael J. Overman, Cathy Eng
Vydáno 2020Artigo -
17
Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers Autor Rachna T. Shroff, Milind Javle, Lianchun Xiao, Ahmed O. Kaseb, Gauri R. Varadhachary, Robert A. Wolff, Kanwal Raghav, Michiko Iwasaki, Peter Masci, Ramesh K. Ramanathan, Daniel H. Ahn, Tanios Bekaii‐Saab, Mitesh J. Borad
Vydáno 2019Artigo -
18
<i>FBXW7</i> missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma Autor Krittiya Korphaisarn, Van K. Morris, Michael J. Overman, David R. Fogelman, Bryan K. Kee, Kanwal Raghav, Shanequa Manuel, Imad Shureiqi, Robert A. Wolff, Cathy Eng, David G. Menter, Stanley R. Hamilton, Scott Kopetz, Arvind Dasari
Vydáno 2017Artigo -
19
Phase I trial of the combination of the pan-ErbB inhibitor neratinib and mTOR inhibitor everolimus in advanced cancer patients with family gene alterations Autor Sarina A. Piha‐Paul, Chieh Tseng, Hai T. Tran, Aung Naing, Ecaterina E. Dumbrava, DD Karp, Jordi Rodón, Timothy A. Yap, Kanwal Raghav, Senthil Damodaran, Xiao‐Feng Le, P.T. Soliman, Jo Ann Lim, F. Meric-Bernstam
Vydáno 2025Artigo -
20
Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Revi... Autor Shen, Chan, Tannenbaum, Daniel, Horn, Robert, Rogers, Jane, Eng, Cathy, Zhou, Shouhao, Johnson, Benny, Kopetz, Scott, Morris, Van, Overman, Michael, Parseghian, Christine, Chang, George J., Lopez-Olivo, Maria A., Kanwal, Raghav, Ellis, Lee M., Dasari, Arvind
Vydáno 2022Text
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Cancer
Oncology
Colorectal cancer
Biology
Cancer research
Gene
Gastroenterology
Genetics
Clinical trial
Cohort
Chemotherapy
KRAS
Breast cancer
Confidence interval
Surgery
Clinical endpoint
Immunotherapy
Adenocarcinoma
Cetuximab
Hazard ratio
Proportional hazards model
Bevacizumab
Biochemistry
Bioinformatics
Environmental health
Epidermal growth factor receptor
Oxaliplatin
Pathology